CRISPR-Cas9 Mode of Action
September 14, 1990 was the first FDA approved human clinical trial for gene therapy. The patient, then [MORE]
Mouse Fetus
Hematopoietic stem cell transplants in utero have potential for “curing” genetic diseases before birth. In 1995, Drs. Alan [MORE]